• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY® URETERAL STENT WITH HYDROGLIDE¿ GUIDEWIRE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY® URETERAL STENT WITH HYDROGLIDE¿ GUIDEWIRE Back to Search Results
Model Number 777626
Device Problems Biocompatibility (2886); Patient Device Interaction Problem (4001)
Patient Problems Pain (1994); Skin Discoloration (2074); Swelling/ Edema (4577)
Event Date 11/22/2021
Event Type  Injury  
Event Description
It was reported that a (b)(6) male patient was admitted to the hospital due to difficulty in urinating.After admission, the doctor diagnosed benign prostatic hyperplasia, and at 10:20 on november 22, the patient was divided into an indwelling ureteral stent.At 17:00, the patient reported that the urethral orifice was painful and accompanied by white secretions.The doctor found that the urethral orifice was red and swollen after examination, so the ureteral stent was removed, and symptomatic anti-inflammatory treatment was given.At 8:30 on november 23, the doctor checked during the rounds.The patient's urethral orifice was normal and there was no secretion.
 
Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.The device was not returned.
 
Manufacturer Narrative
The reported event was inconclusive.No sample was returned for evaluation.A potential root cause for this event could be, "material selection".The device was used for treatment purposes, however, since the device was not returned it is unknown if it had met relevant specifications or contributed to the reported event.The device history record was reviewed and found nothing that could have caused or contributed to the reported event.The instructions for use were found adequate and state the following: "potential complications associated with retrograde/antegrade positioning of indwelling ureteral stents include the following: ¿ edema ¿ stone formation ¿ peritonitis ¿ extravasation ¿ ureteral reflux ¿ stent dislogdgement, fragmentation, migration, occlusion ¿ fistula formation ¿ loss of renal function ¿ hemorrhage ¿ pain/discomfort ¿ stent encrustation ¿ hydronephrosis ¿ perforation of kidney, renal pelvis, ureter and/or bladder ¿ ureteral erosion ¿ infection ¿ urinary symptoms"."determine the proper stent length for the patient.This is generally calculated from the baseline pyelogram.Accurate measurements will optimize drainage efficiency and patient comfort.Submerge stent in sterile water to activate the coating." h11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported that the patient was admitted to the hospital due to difficulty in urinating.After admission, the doctor diagnosed benign prostatic hyperplasia, and at 10:20 on (b)(6), the patient was divided into an indwelling ureteral stent.At 17:00, the patient reported that the urethral orifice was painful and accompanied by white secretions.The doctor found that the urethral orifice was red and swollen after examination, so the ureteral stent was removed, and symptomatic anti-inflammatory treatment was given.At 8:30 on (b)(6), the doctor checked during the rounds.The patient's urethral orifice was normal and there was no secretion.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BARD® INLAY® URETERAL STENT WITH HYDROGLIDE¿ GUIDEWIRE
Type of Device
URETERAL STENT
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington 30014
Manufacturer (Section G)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington 30014
Manufacturer Contact
yonic anderson
8195 industrial blvd
covington 30014
7707846100
MDR Report Key13003180
MDR Text Key282976757
Report Number1018233-2021-08036
Device Sequence Number1
Product Code FAD
UDI-Device Identifier10801741014557
UDI-Public(01)10801741014557
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K983498
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/18/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number777626
Device Catalogue Number777626
Device Lot NumberNGEW3164
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/29/2021
Initial Date FDA Received12/14/2021
Supplement Dates Manufacturer Received04/19/2022
Supplement Dates FDA Received05/12/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/20/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age61 YR
Patient SexMale
-
-